ARCHIVES

In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores

This article is from The Cancer Letter archive.

Vol. 07 No. 24 | June 12, 1981

Download PDF Visit The Full Archive

Related Articles

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

September 24, 1999

In Brief: CT Scanning Reduced Morbidity, Mortality, Helps Deliver Optimal Treatment, Consensus Panel Says

November 27, 1981

In Brief: Antman, Chabner Vie For ASCO President-Elect; Irwin Krakoff Is 1993 Karnofsky Lecturer

January 8, 1993

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013

St. Jude Children’s wins NCI contract for Pediatric Preclinical Testing Program.

November 12, 2004